Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Biomass derived surfactant molecules by reacting HMF,glycerol and fatty alcohols in one pot process with heterogeneous acid catalysts of controlled polarity.

Corma A, Garcia Ortiz A, Arias K, Climent MJ, Iborra S.

ChemSusChem. 2018 Jul 5. doi: 10.1002/cssc.201801132. [Epub ahead of print]

PMID:
29975011
2.

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT and TEXT Investigators and the International Breast Cancer Study Group.

N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4.

PMID:
29863451
3.

[Multidisciplinary teams in the treatment of prostate cancer.]

Climent MÁ, Rubio-Briones J.

Arch Esp Urol. 2018 Mar;71(3):315-322. Spanish.

PMID:
29633953
4.

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

Vaughn DJ, Bellmunt J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Li H, Perini RF, Bajorin DF, de Wit R.

J Clin Oncol. 2018 Jun 1;36(16):1579-1587. doi: 10.1200/JCO.2017.76.9562. Epub 2018 Mar 28.

PMID:
29590008
5.

Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

Cassinello J, Arranz JÁ, Piulats JM, Sánchez A, Pérez-Valderrama B, Mellado B, Climent MÁ, Olmos D, Carles J, Lázaro M.

Clin Transl Oncol. 2018 Jan;20(1):110-111. doi: 10.1007/s12094-017-1823-y.

PMID:
29305743
6.

Systematic review and survival meta-analysis of real world evidence on first-line pazopanib for metastatic renal cell carcinoma.

Climent MA, Muñoz-Langa J, Basterretxea-Badiola L, Santander-Lobera C.

Crit Rev Oncol Hematol. 2018 Jan;121:45-50. doi: 10.1016/j.critrevonc.2017.11.009. Epub 2017 Nov 16. Review.

PMID:
29279098
7.

Historical anthropogenic mercury in two lakes of Central Chile: comparison between an urban and rural lake.

Álvarez D, Torrejón F, Climent MJ, Garcia-Orellana J, Araneda A, Urrutia R.

Environ Sci Pollut Res Int. 2018 Feb;25(5):4596-4606. doi: 10.1007/s11356-017-0622-x. Epub 2017 Nov 30.

PMID:
29192400
8.

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).

Cassinello J, Arranz JÁ, Piulats JM, Sánchez A, Pérez-Valderrama B, Mellado B, Climent MÁ, Olmos D, Carles J, Lázaro M.

Clin Transl Oncol. 2018 Jan;20(1):57-68. doi: 10.1007/s12094-017-1783-2. Epub 2017 Nov 13. Erratum in: Clin Transl Oncol. 2018 Jan 5;:.

9.

Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.

Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D.

Eur J Cancer. 2017 Dec;87:30-37. doi: 10.1016/j.ejca.2017.09.028. Epub 2017 Nov 2.

PMID:
29102858
10.

Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223.

Rodriguez-Vida A, Torregrosa MD, Pinto Á, Climent MÁ, Olmos D, Carles J.

Clin Transl Oncol. 2018 Jun;20(6):679-686. doi: 10.1007/s12094-017-1785-0. Epub 2017 Nov 2. Review.

PMID:
29098556
11.

Performance of Sustainable Fly Ash and Slag Cement Mortars Exposed to Simulated and Real In Situ Mediterranean Conditions along 90 Warm Season Days.

Ortega JM, Esteban MD, Sánchez I, Climent MÁ.

Materials (Basel). 2017 Oct 31;10(11). pii: E1254. doi: 10.3390/ma10111254.

12.

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

Fizazi K, Ulys A, Sengeløv L, Moe M, Ladoire S, Thiery-Vuillemin A, Flechon A, Guida A, Bellmunt J, Climent MA, Chowdhury S, Dumez H, Matouskova M, Penel N, Liutkauskiene S, Stachurski L, Sternberg CN, Baton F, Germann N, Daugaard G.

Ann Oncol. 2017 Nov 1;28(11):2741-2746. doi: 10.1093/annonc/mdx487.

PMID:
29059273
13.

Impedance Spectroscopy Study of the Effect of Environmental Conditions on the Microstructure Development of Sustainable Fly Ash Cement Mortars.

Ortega JM, Sánchez I, Climent MÁ.

Materials (Basel). 2017 Sep 25;10(10). pii: E1130. doi: 10.3390/ma10101130.

14.

Short-Term Behavior of Slag Concretes Exposed to a Real In Situ Mediterranean Climate Environment.

Ortega JM, Sánchez I, Cabeza M, Climent MÁ.

Materials (Basel). 2017 Aug 8;10(8). pii: E915. doi: 10.3390/ma10080915.

15.

Long-Term Behaviour of Fly Ash and Slag Cement Grouts for Micropiles Exposed to a Sulphate Aggressive Medium.

Ortega JM, Esteban MD, Rodríguez RR, Pastor JL, Ibanco FJ, Sánchez I, Climent MÁ.

Materials (Basel). 2017 May 30;10(6). pii: E598. doi: 10.3390/ma10060598.

16.

Influence of Silica Fume Addition in the Long-Term Performance of Sustainable Cement Grouts for Micropiles Exposed to a Sulphate Aggressive Medium.

Ortega JM, Esteban MD, Rodríguez RR, Pastor JL, Ibanco FJ, Sánchez I, Climent MÁ.

Materials (Basel). 2017 Aug 2;10(8). pii: E890. doi: 10.3390/ma10080890.

17.

Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme.

Climent M, Pera M, Aymar I, Ramón JM, Grande L, Nogués X.

J Bone Miner Metab. 2018 Jul;36(4):462-469. doi: 10.1007/s00774-017-0856-1. Epub 2017 Aug 1.

PMID:
28766134
18.

A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).

García-Donas J, Leon LA, Esteban E, Vidal-Mendez MJ, Arranz JA, Garcia Del Muro X, Basterretxea L, González Del Alba A, Climent MA, Virizuela JA, Álvarez C, Sepúlveda J, Anido U, López C, Ortiz-Morales MJ, Pérez X, Rodriguez-Antona C, Rodriguez-Moreno JF, Hernando S, Castellano D.

Eur Urol Focus. 2017 Oct;3(4-5):430-436. doi: 10.1016/j.euf.2016.09.004. Epub 2016 Oct 4.

PMID:
28753791
19.

Pulmonary Thromboembolism as a First Manifestation of Atrial Myxoma.

Climent M, Furest I, Martínez Moragón E.

Arch Bronconeumol. 2018 Jan;54(1):46-47. doi: 10.1016/j.arbres.2017.05.020. Epub 2017 Jul 3. English, Spanish. No abstract available.

20.

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies.

Castellano D, Maroto JP, Espinosa E, Grande E, Bolós MV, Llinares J, Esteban E, González Del Alba A, Climent MA, Arranz JA, Méndez MJ, Fernández Parra E, Antón-Aparicio L, Bayona C, Gallegos I, Gallardo E, Samaniego L, García Donas J.

Expert Opin Drug Saf. 2018 Jun;17(6):573-579. doi: 10.1080/14740338.2017.1330410. Epub 2017 Aug 28.

PMID:
28535693

Supplemental Content

Loading ...
Support Center